Essenlix iMOST (Instant Mobile Self-Test)
Replaces inconvenient and expensive traditional in-person lab-testing with a mobile-phone device that is accurate, fast (60 seconds or less), affordable, and uses one drop of body fluid. Can be used by anyone, anywhere, with results sent instantly to healthcare professionals.
About
Essenlix is a digital health company that uses its ground-breaking innovation, the iMOST (Instant Mobile Self-Test), to transform healthcare and beyond.
The lack of instant health testing that an individual can perform remotely is the largest barrier to digital health. Essenlix iMOST has removed that.
Essenlix aims at fundamentally altering medical diagnostics, health monitoring, and telemedicine landscape, and profoundly impacting hundred millions of lives or more globally - from large population centers to remote villages.
The lack of instant health testing that an individual can perform remotely is the largest barrier to digital health. Essenlix iMOST has removed that.
Essenlix aims at fundamentally altering medical diagnostics, health monitoring, and telemedicine landscape, and profoundly impacting hundred millions of lives or more globally - from large population centers to remote villages.
Vision
Providing the Missing Link, Driving a Paradigm Shift in Diagnostic Testing
|
Digital personal health has often been predicted to be the next major advancement in healthcare. However, that has yet to become a reality in large part because of the lack of a reliable instant self-test platform for biomarkers that is digital, rapid, affordable and mobile that can also be used by anyone, anywhere. Without this platform the innovations promised by digital health will be greatly limited.
Essenlix aims to be this platform. By providing the missing link between biomarkers in the human body and instant digitized results the iMOST platform will not only drive a major paradigm shift in conventional diagnostic testing and health monitoring, but also significantly advance digital personal health. |
|
Company
Founded in 2013 by Dr. Stephen Chou and Dr. Lin Chou M.D., Essenlix has brought together a multidisciplinary albeit unconventional team from business, industry, and academia. Collectively, the group possesses vast expertise in business, technology and product development.
Essenlix has attracted a group of experienced investors including Quadrant Management and Carret Private Investments.
Essenlix has attracted a group of experienced investors including Quadrant Management and Carret Private Investments.
Technology
Use Disruptive Innovations to make Instant Mobile Health Testing Dream a Reality
Essenlix developed iMOST using unconventional disruptive approaches based on a fundamentally different paradigm from conventional lab-testing. One of the Essenlix’s core innovations is how to achieve accurate test results under imperfect resource-limited test conditions. Essenlix iMOST uniquely uses and integrates numerous best modern technologies in multiple disciplines including biotechnology, nanotechnology, advanced imaging, artificial intelligence, and machine learning.
|
Furthermore, Essenlix iMOST is built on the vast technology and product development expertise of Essenlix’s multidisciplinary team of industry and academia veterans.
Essenlix iMOST puts a mobile chemical biological lab in your hand. |
Products
Replacing Inconvenient and Expensive Lab-Test
|
|
Complete Blood Counts at Your Finger Tip
|
Essenlix iMOST performs CBC tests by mobile phone in 60 seconds or less, simply and accurately.
|
Contact Us
|
Essenlix Corporation
1 Deerpark Drive, Suite R, Monmouth Junction, NJ 08852 +1 732-274-1020 +1 732-274-1021 |
info@essenlix.com
|